An open‐label, multicenter, efficacy, and safety study of deferasirox in iron‐overloaded patients with non‐transfusion‐dependent thalassemia (THETIS): 5‐year results. Issue 8 (27th May 2022) - Lai, Yong‐Rong; Cappellini, Maria Domenica; Aydinok, Yesim; Porter, John; Karakas, Zeynep; Viprakasit, Vip; Siritanaratkul, Noppadol; Kattamis, Antonis; Liu, Rongrong; Izquierdo, Miguel; Lasher, Janet; Govindaraju, Sameera; et al.